Analysis of protection afforded by a Clostridium perfringens α-toxoid against heterologous clostridial phospholipases C

Microbial Pathogenesis

Volumn 43, Issue 4, 2007, Pages 161-165

  Neeson, Brendan N ^a   Clark, Graeme C ^a   Atkins, Helen S ^a   Lingard, Bryan ^a   Titball, Richard W ^a,b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Clostridium perfringens; Myonecrosis; Phospholipase C; Vaccine

Indexed keywords

BACTERIAL VACCINE; CLOSTRIDIUM PERFRINGENS TOXOID; FREUND ADJUVANT; PHOSPHOLIPASE C; TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CLOSTRIDIUM ABSONUM; CLOSTRIDIUM BIFERMENTANS; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; FEMALE; GAS GANGRENE; IMMUNIZATION; IN VIVO STUDY; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL TOXINS; BACTERIAL VACCINES; CALCIUM-BINDING PROTEINS; CATTLE; CLOSTRIDIUM BIFERMENTANS; CLOSTRIDIUM INFECTIONS; CLOSTRIDIUM PERFRINGENS; CROSS REACTIONS; FEMALE; MICE; MICE, INBRED BALB C; PHOSPHOLIPASE C; RECOMBINANT PROTEINS;

CLOSTRIDIUM PERFRINGENS; MUS;

EID: 34547574258     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.05.004     Document Type: Article

References (24)

1. Titball R.W. Gas gangrene: an open and shut case. Microbiology 151 (2005) 2821-2828
2. Awad M.M., Ellemor D.M., Boyd R.L., et al. Synergistic effects of alpha-toxin and perfringolysin O in Clostridium perfringens-mediated gas gangrene. Infect Immun 69 (2001) 7904-7910
3. Chapnick E.K., and Abter E.I. Necrotizing soft-tissue infections. Infect Dis Clin N Am 10 (1996) 835-855
4. Gonzalez M.H. Necrotizing fascitis and gangrene of the upper extremity. Hand Clin 14 (1998) 345-635
5. Hoover T.J., and Siefert J.A. Soft tissue complications of orthopedic emergencies. Orthop Emerg 18 (2000) 115-139
6. Sakai T., Nanjo H., Takahashi M., et al. Non-traumatic gas gangrene in the abdomen: report of six autopsy cases. J Gastroenterol 35 (2000) 382-390
7. Awad M.M., Bryant A.E., Stevens D.L., and Rood J.I. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha-toxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol 15 2 (1995) 191-202
8. Ninomiya M., Matsushita O., Minami J., Sakamoto H., Nakano M., and Okabe A. Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of Clostridium perfringens and Bacillus subtilis. Infect Immun 62 11 (1994) 5032-5039
9. Titball R.W., Leslie D.L., Harvey S., and Kelly D. Haemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic-acid pathway. Infect Immun 59 5 (1991) 1872-1874
10. Jepson M., Howells A., Bullifent H.L., et al. Differences in the carboxy-terminal (putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the haemolytic and lethal properties of these enzymes. Infect Immun 67 7 (1999) 3297-3301
11. Nagahama M., Mukai M., Morimitsu S., et al. Role of the C-domain in the biological activities Clostridium perfringens alpha-toxin. Microbiol Immunol 46 (2002) 647-655
12. Naylor C.E., Eaton J.T., Howells A., et al. Structure of the key toxin in gas gangrene. Nat Struct Biol 5 8 (1998) 738-746
13. Titball R.W., Naylor C.E., Miller J., et al. Opening of the active site of Clostridium perfringens alpha-toxin may be triggered by membrane binding. Int J Med Microbiol 290 (2000) 357-361
14. Wierup M. The Swedish experience of the 1986 year ban of antimicrobial growth promoters, with special reference to animal health, disease prevention, productivity, and usage of antimicrobials. Microb Drug Res Mech Epidemiol Dis 7 (2001) 183-190
15. Manteca C., Daube G., Pirson V., Limbourg B., Kaeckenbeeck A., and Mainil J.G. Bacterial intestinal flora associated with enterotoxaemia in Belgian Blue calves. Vet Microbiol 81 1 (2001) 21-32
16. Justin N., Walker N., Bullifent H.L., et al. The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic properties. Biochemistry 41 (2002) 6253-6262
17. Clark G.C., Briggs D.C., Karasawa T., et al. Clostridium absonum alpha-toxin: new insights into clostridial phospholipase C substrate binding and specificity. J Mol Biol 333 4 (2003) 759-769
18. Jepson M., Howells A., Bullifent H.L., et al. Differences in the carboxy-terminal (putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the haemolytic and lethal properties of these enzymes. Infect Immun 67 7 (1999) 3297-3301
19. Titball R.W., Fearn A.M., and Williamson E.D. Biochemical and immunological properties of the C-terminal domain of the alpha-toxin of Clostridium perfringens. FEMS Microbiol Lett 110 1 (1993) 45-50
20. Stevens D.L., Titball R.W., Jepson M., Bayer C.R., Hayes-Schroer S.M., and Bryant A.E. Immunisation with the C-domain of alpha-toxin prevents lethal infection, localises tissue injury, and promotes host response to challenge with Clostridium perfringens. J Infect Dis 190 (2004) 767-773
21. Williamson E.D., and Titball R.W. A genetically-engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas-gangrene. Vaccine 11 12 (1993) 1253-1258
22. Bennett A.M., Lescott T., Phillpotts R.J., et al. Recombinant Vaccinia virus protects against Clostridium perfringens α-toxin. Viral Immunol 12 2 (1999) 97-105
23. Ginter A., Williamson E.D., Dessy F., et al. Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals. Microbiology-UK 142 (1996) 191-198
24. Schoepe H., Neubauer A., Schlapp T., et al. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin. Anaerobe 12 (2006) 44-48